Inhibrx
INBX
$34.39
Share price
0.26%
Change (1 day)
30.02%
Change (1 year)
Categories
Operating Margin for Inhibrx (INBX)
Operating Margin as of May 2024 (TTM): -12,725.40%
According to Inhibrx's latest financial reports and stock price the company's current Operating Margin is -12,725.40%. At the end of 2021 the company had an Operating Margin of -1,147.59%.
Operating Margin history for Inhibrx from 2019 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -1,147.59% | 94.34% |
| 2020 | -590.52% | 6.32% |
| 2019 | -555.39% | 34.7% |
| 2018 | -412.33% | 50.16% |
| 2017 | -274.59% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.